WGU D027 OBJECTIVE ASSESSMENT ACTUAL 2026/2027 |
Advanced Pathopharmacological Foundations Review |
Questions & Verified Answers 100% Correct | Pass
Guaranteed - A+ Graded
Principles of Pharmacology: PK/PD, ADME, and Receptors
Q1: A 72-year-old patient with heart failure is started on digoxin 0.125 mg daily. for rate
control in atrial fibrillation. The nurse practitioner reviews the pharmacokinetic profile to
determine when steady state will be reached. Steady state is typically achieved after
how many half-lives?
A. 2-3 half-lives
B. 1-2 half-lives
C. 4-5 half-lives [CORRECT]
D. 7-10 half-lives
Correct Answer: C
Rationale: Steady state plasma concentration is achieved when the rate of drug
administration equals the rate of elimination. This typically occurs after 4-5 half-lives of
the drug. Digoxin has a half-life of approximately 36-48 hours, so steady state would be
reached in about 7-10 days with daily dosing.
Q2: Which factor has the greatest impact on the oral bioavailability of a medication?
A. First-pass hepatic metabolism
B. Intravenous administration route
C. Gastrointestinal blood flow
D. Patient's psychological state
Correct Answer: A
Rationale: First-pass metabolism refers to the metabolism of a drug in the liver before it
reaches systemic circulation. This significantly reduces bioavailability for many drugs.
IV administration bypasses first-pass metabolism entirely, while GI blood flow and
patient psychology have minimal impact on bioavailability calculations.
,Q3: A nurse practitioner is counseling a patient prescribed transdermal fentanyl for
chronic cancer pain. Which statement best describes the pharmacokinetic advantage of
this route?
A. Avoids first-pass metabolism but has erratic absorption due to skin thickness
variations
B. Provides sustained plasma levels with avoidance of first-pass metabolism
C. Bypasses first-pass metabolism and providing sustained plasma levels over 72 hours
[CORRECT]
D. Transdermal absorption is faster than oral absorption for breakthrough pain
Correct Answer: C
Rationale: Transdermal fentanyl patches provide continuous drug delivery over 72
hours, maintaining steady plasma concentrations. They bypass first-pass hepatic
metabolism and but absorption is slower than oral routes, not faster. Skin thickness
affects absorption rate but not the fundamental pharmacokinetic advantage.
Q4: Which protein is primarily responsible for binding acidic drugs in plasma?
A. Alpha-1 acid glycoprotein (AAG)
B. Albumin [CORRECT]
C. Globulins
D. Lipoproteins
Correct Answer: B
Rationale: Albumin is the most abundant plasma protein and primarily binds acidic
drugs. Alpha-1 acid glycoprotein binds basic drugs. Albumin binding affects volume of
distribution and drug interactions.
Q5: A patient with liver cirrhosis is prescribed lorazepam 2 mg IV for alcohol withdrawal.
The nurse practitioner should anticipate which pharmacokinetic change?
A. Reduced hepatic metabolism leading to increased drug effect
B. No significant change because IV route bypasses liver
C. Reduced clearance but this does not affect IV administration
D. Phase I metabolism is unchanged in liver disease
Correct Answer: A
Rationale: While IV administration bypasses first-pass metabolism, lorazepam
undergoes glucuronidation (Phase II) in the liver. In cirrhosis, reduced hepatic blood flow
,and impaired hepatocyte function decrease metabolism and clearance of even IV drugs,
leading to increased effect and potential accumulation.
Q6: Which CYP450 enzyme is responsible for metabolizing approximately 50% of
clinically used drugs?
A. CYP2D6
B. CYP3A4 [CORRECT]
C. CYP1A2
D. CYP2C9
Correct Answer: B
Rationale: CYP3A4 is the most abundant cytochrome P450 enzyme in the liver and
metabolizes approximately 50% of all clinically used medications. It is involved in
numerous significant drug-drug interactions.
Q7: A patient on carbamazepine for seizures is started on a new medication. The nurse
practitioner recognizes carbamazepine as a CYP450 inducer. Which effect on
concurrently administered drugs metabolized by the same enzyme should be
anticipated?
A. Increased drug levels due to inhibited metabolism
B. Decreased drug levels due to increased metabolism [CORRECT]
C. No change in drug levels
D. Increased toxicity due to accumulation
Correct Answer: B
Rationale: Carbamazepine induces (increases) CYP450 enzyme activity, leading to
faster metabolism and reduced plasma levels of drugs metabolized by the same
enzyme. This is particularly important for drugs like oral contraceptives, warfarin, and
cyclosporine.
Q8: Which substance is a potent CYP3A4 inhibitor that significantly increases levels of
many statins and calcium channel blockers, and immunosuppressants?
A. Rifampin
B. Grapefruit juice [CORRECT]
C. St. John's wort
D. Phenytoin
Correct Answer: B
, Rationale: Grapefruit juice contains furanocoumarins that irreversibly inhibit CYP3A4,
significantly increasing levels of substrates like atorvastatin, simvastatin, and
cyclosporine. This interaction lasts 24-72 hours and requires medication holds or
avoidance.
Q9: A patient with CYP2D6 poor metabolizer status is prescribed codeine for
post-operative pain. What is the expected clinical outcome?
A. Normal analgesic effect
B. Reduced analgesic effect due to lack of morphine conversion [CORRECT]
C. Increased sedation from morphine toxicity
D. No change in pain control
Correct Answer: B
Rationale: Codeine is a prodrug requiring CYP2D6 metabolism to convert to morphine
for analgesic effect. Poor metabolizers cannot efficiently convert codeine, resulting in
inadequate pain relief. Ultra-rapid metabolizers may experience toxicity.
Q10: The nurse practitioner is reviewing pharmacodynamic principles. Full agonists are
characterized by:
A. Binding to receptor without producing biological response
B. Producing maximum biological response when all receptors occupied [CORRECT]
C. Blocking receptor to prevent endogenous ligand binding
D. Producing partial response even at full receptor occupancy
Correct Answer: B
Rationale: Full agonists bind to receptors and produce the maximum possible biological
response (Emax). Partial agonists produce submaximal response, antagonists block
receptor binding without activation, and inverse agonists produce opposite effects.
Q11: A patient receiving a new medication demonstrates dose-dependent toxicity at
therapeutic doses. This describes which type of adverse drug reaction?
A. Type A (augmented/predictable) [CORRECT]
B. Type B (bizarre/idiosyncratic)
C. Type C (chronic)
D. Type D (delayed)
Correct Answer: A
Advanced Pathopharmacological Foundations Review |
Questions & Verified Answers 100% Correct | Pass
Guaranteed - A+ Graded
Principles of Pharmacology: PK/PD, ADME, and Receptors
Q1: A 72-year-old patient with heart failure is started on digoxin 0.125 mg daily. for rate
control in atrial fibrillation. The nurse practitioner reviews the pharmacokinetic profile to
determine when steady state will be reached. Steady state is typically achieved after
how many half-lives?
A. 2-3 half-lives
B. 1-2 half-lives
C. 4-5 half-lives [CORRECT]
D. 7-10 half-lives
Correct Answer: C
Rationale: Steady state plasma concentration is achieved when the rate of drug
administration equals the rate of elimination. This typically occurs after 4-5 half-lives of
the drug. Digoxin has a half-life of approximately 36-48 hours, so steady state would be
reached in about 7-10 days with daily dosing.
Q2: Which factor has the greatest impact on the oral bioavailability of a medication?
A. First-pass hepatic metabolism
B. Intravenous administration route
C. Gastrointestinal blood flow
D. Patient's psychological state
Correct Answer: A
Rationale: First-pass metabolism refers to the metabolism of a drug in the liver before it
reaches systemic circulation. This significantly reduces bioavailability for many drugs.
IV administration bypasses first-pass metabolism entirely, while GI blood flow and
patient psychology have minimal impact on bioavailability calculations.
,Q3: A nurse practitioner is counseling a patient prescribed transdermal fentanyl for
chronic cancer pain. Which statement best describes the pharmacokinetic advantage of
this route?
A. Avoids first-pass metabolism but has erratic absorption due to skin thickness
variations
B. Provides sustained plasma levels with avoidance of first-pass metabolism
C. Bypasses first-pass metabolism and providing sustained plasma levels over 72 hours
[CORRECT]
D. Transdermal absorption is faster than oral absorption for breakthrough pain
Correct Answer: C
Rationale: Transdermal fentanyl patches provide continuous drug delivery over 72
hours, maintaining steady plasma concentrations. They bypass first-pass hepatic
metabolism and but absorption is slower than oral routes, not faster. Skin thickness
affects absorption rate but not the fundamental pharmacokinetic advantage.
Q4: Which protein is primarily responsible for binding acidic drugs in plasma?
A. Alpha-1 acid glycoprotein (AAG)
B. Albumin [CORRECT]
C. Globulins
D. Lipoproteins
Correct Answer: B
Rationale: Albumin is the most abundant plasma protein and primarily binds acidic
drugs. Alpha-1 acid glycoprotein binds basic drugs. Albumin binding affects volume of
distribution and drug interactions.
Q5: A patient with liver cirrhosis is prescribed lorazepam 2 mg IV for alcohol withdrawal.
The nurse practitioner should anticipate which pharmacokinetic change?
A. Reduced hepatic metabolism leading to increased drug effect
B. No significant change because IV route bypasses liver
C. Reduced clearance but this does not affect IV administration
D. Phase I metabolism is unchanged in liver disease
Correct Answer: A
Rationale: While IV administration bypasses first-pass metabolism, lorazepam
undergoes glucuronidation (Phase II) in the liver. In cirrhosis, reduced hepatic blood flow
,and impaired hepatocyte function decrease metabolism and clearance of even IV drugs,
leading to increased effect and potential accumulation.
Q6: Which CYP450 enzyme is responsible for metabolizing approximately 50% of
clinically used drugs?
A. CYP2D6
B. CYP3A4 [CORRECT]
C. CYP1A2
D. CYP2C9
Correct Answer: B
Rationale: CYP3A4 is the most abundant cytochrome P450 enzyme in the liver and
metabolizes approximately 50% of all clinically used medications. It is involved in
numerous significant drug-drug interactions.
Q7: A patient on carbamazepine for seizures is started on a new medication. The nurse
practitioner recognizes carbamazepine as a CYP450 inducer. Which effect on
concurrently administered drugs metabolized by the same enzyme should be
anticipated?
A. Increased drug levels due to inhibited metabolism
B. Decreased drug levels due to increased metabolism [CORRECT]
C. No change in drug levels
D. Increased toxicity due to accumulation
Correct Answer: B
Rationale: Carbamazepine induces (increases) CYP450 enzyme activity, leading to
faster metabolism and reduced plasma levels of drugs metabolized by the same
enzyme. This is particularly important for drugs like oral contraceptives, warfarin, and
cyclosporine.
Q8: Which substance is a potent CYP3A4 inhibitor that significantly increases levels of
many statins and calcium channel blockers, and immunosuppressants?
A. Rifampin
B. Grapefruit juice [CORRECT]
C. St. John's wort
D. Phenytoin
Correct Answer: B
, Rationale: Grapefruit juice contains furanocoumarins that irreversibly inhibit CYP3A4,
significantly increasing levels of substrates like atorvastatin, simvastatin, and
cyclosporine. This interaction lasts 24-72 hours and requires medication holds or
avoidance.
Q9: A patient with CYP2D6 poor metabolizer status is prescribed codeine for
post-operative pain. What is the expected clinical outcome?
A. Normal analgesic effect
B. Reduced analgesic effect due to lack of morphine conversion [CORRECT]
C. Increased sedation from morphine toxicity
D. No change in pain control
Correct Answer: B
Rationale: Codeine is a prodrug requiring CYP2D6 metabolism to convert to morphine
for analgesic effect. Poor metabolizers cannot efficiently convert codeine, resulting in
inadequate pain relief. Ultra-rapid metabolizers may experience toxicity.
Q10: The nurse practitioner is reviewing pharmacodynamic principles. Full agonists are
characterized by:
A. Binding to receptor without producing biological response
B. Producing maximum biological response when all receptors occupied [CORRECT]
C. Blocking receptor to prevent endogenous ligand binding
D. Producing partial response even at full receptor occupancy
Correct Answer: B
Rationale: Full agonists bind to receptors and produce the maximum possible biological
response (Emax). Partial agonists produce submaximal response, antagonists block
receptor binding without activation, and inverse agonists produce opposite effects.
Q11: A patient receiving a new medication demonstrates dose-dependent toxicity at
therapeutic doses. This describes which type of adverse drug reaction?
A. Type A (augmented/predictable) [CORRECT]
B. Type B (bizarre/idiosyncratic)
C. Type C (chronic)
D. Type D (delayed)
Correct Answer: A
